What does Apotheek D'HEER Pharma do?

Apotheek D'HEER Pharma is a pharmacy in Lokeren. Private Limited, started on 19 December 1991, 1 establishment.

What is the address of Apotheek D'HEER Pharma?

The registered office of Apotheek D'HEER Pharma is located at Doorslaardorp 85, 9160 Lokeren.

Is Apotheek D'HEER Pharma still active?

Yes. According to the CBE (30 October 2026) Apotheek D'HEER Pharma is active, legal situation “Normale toestand”, started on 19 December 1991.

Is Apotheek D'HEER Pharma registered on Peppol?

Yes, Apotheek D'HEER Pharma is registered on the Peppol network with ID 0208:0446071227.

What is the enterprise number of Apotheek D'HEER Pharma?

The enterprise number of Apotheek D'HEER Pharma is BE0446071227.

When was Apotheek D'HEER Pharma founded?

Apotheek D'HEER Pharma was founded on 19 December 1991.

Who are the directors of Apotheek D'HEER Pharma?

According to the 2025 annual accounts, the directors of Apotheek D'HEER Pharma are: Axarka Comm V.

Is Apotheek D'HEER Pharma a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 December 1991; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek D'HEER Pharma make in 2025?

Apotheek D'HEER Pharma posted a profit after taxes of € 1,157 in financial year 2025.

What is the revenue of Apotheek D'HEER Pharma?

As a small company, Apotheek D'HEER Pharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 101,803.

How much does an employee at Apotheek D'HEER Pharma earn?

The average wage cost per full-time employee at Apotheek D'HEER Pharma was € 55,500 in 2025: staff costs of € 83,185 for 1.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek D'HEER Pharma have?

According to the 2025 annual accounts, Apotheek D'HEER Pharma has 1.5 full-time equivalents (FTE).

Apotheek D'HEER Pharma (Private Limited) - Lokeren

Dossier Apotheek D'HEER Pharma, printed on 30 October 2026 from databakkes.be/en/0446071227/apotheek-d-heer-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 15 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Apotheek D'HEER Pharma from Lokeren, company number BE0446071227, closed financial year 2025 with a result of € 1,157 after tax. For that financial year Apotheek D'HEER Pharma recorded a gross margin of € 101,803 and equity of € 170,028. Compared with financial year 2024, the result moved from € 3,916 to € 1,157. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 17, 2026.

What it is worth Growing

€ 170,028

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 1,157

▼ 70% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 21,004

▼ 48% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 157,628.

People and assets in 2025

Full-time equivalents

1.5

▼ 0.7 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 83,185

▼ 43% vs 2024

€ 55,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,711

▼ 49% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 11 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 291,727

▼ 5% vs 2024

€ 15,654 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Owed to suppliers

€ 84,559

▲ 30% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 10,574

▼ 46% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 134,855 Gross margin 2022: € 134,855 First fiscal year in the series	€ 102,993 Gross margin 2023: € 102,993 ▼ 24% vs 2022 (€ 134,855) Unfavourable step	€ 168,527 Gross margin 2024: € 168,527 ▲ 64% vs 2023 (€ 102,993) Favourable step	€ 101,803 Gross margin 2025: € 101,803 ▼ 40% vs 2024 (€ 168,527) Unfavourable step	▼ 40%
Profit after taxes	€ 38,726 Profit after taxes 2022: € 38,726 First fiscal year in the series	€ 2,574 Profit after taxes 2023: € 2,574 ▼ 93% vs 2022 (€ 38,726) Unfavourable step	€ 3,916 Profit after taxes 2024: € 3,916 ▲ 52% vs 2023 (€ 2,574) Favourable step	€ 1,157 Profit after taxes 2025: € 1,157 ▼ 70% vs 2024 (€ 3,916) Unfavourable step	▼ 70%
Equity	€ 162,382 Equity 2022: € 162,382 First fiscal year in the series	€ 164,955 Equity 2023: € 164,955 ▲ 2% vs 2022 (€ 162,382) Favourable step	€ 168,871 Equity 2024: € 168,871 ▲ 2% vs 2023 (€ 164,955) Favourable step	€ 170,028 Equity 2025: € 170,028 ▲ 1% vs 2024 (€ 168,871) Favourable step	▲ 1%
Total debts	€ 433,484 Total debts 2022: € 433,484 First fiscal year in the series	€ 419,763 Total debts 2023: € 419,763 ▼ 3% vs 2022 (€ 433,484) Favourable step	€ 409,864 Total debts 2024: € 409,864 ▼ 2% vs 2023 (€ 419,763) Favourable step	€ 393,545 Total debts 2025: € 393,545 ▼ 4% vs 2024 (€ 409,864) Favourable step	▼ 4%
Cash	€ 86,063 Cash 2022: € 86,063 First fiscal year in the series	€ 22,669 Cash 2023: € 22,669 ▼ 74% vs 2022 (€ 86,063) Unfavourable step	€ 40,284 Cash 2024: € 40,284 ▲ 78% vs 2023 (€ 22,669) Favourable step	€ 21,004 Cash 2025: € 21,004 ▼ 48% vs 2024 (€ 40,284) Unfavourable step	▼ 48%
Land & buildings	€ 140,220 Land & buildings 2022: € 140,220 First fiscal year in the series	€ 130,573 Land & buildings 2023: € 130,573 ▼ 7% vs 2022 (€ 140,220) Unchanged	€ 118,511 Land & buildings 2024: € 118,511 ▼ 9% vs 2023 (€ 130,573) Unchanged	€ 106,450 Land & buildings 2025: € 106,450 ▼ 10% vs 2024 (€ 118,511) Unchanged	▼ 10%
Retained profit	€ 149,982 Retained profit 2022: € 149,982 First fiscal year in the series	€ 152,555 Retained profit 2023: € 152,555 ▲ 2% vs 2022 (€ 149,982) Favourable step	€ 156,471 Retained profit 2024: € 156,471 ▲ 3% vs 2023 (€ 152,555) Favourable step	€ 157,628 Retained profit 2025: € 157,628 ▲ 1% vs 2024 (€ 156,471) Favourable step	▲ 1%
Bank debt	€ 337,246 Bank debt 2022: € 337,246 First fiscal year in the series	€ 322,303 Bank debt 2023: € 322,303 ▼ 4% vs 2022 (€ 337,246) Favourable step	€ 307,136 Bank debt 2024: € 307,136 ▼ 5% vs 2023 (€ 322,303) Favourable step	€ 291,727 Bank debt 2025: € 291,727 ▼ 5% vs 2024 (€ 307,136) Favourable step	▼ 5%
Balance sheet total	€ 595,865 Balance sheet total 2022: € 595,865 First fiscal year in the series	€ 584,719 Balance sheet total 2023: € 584,719 ▼ 2% vs 2022 (€ 595,865) Unchanged	€ 578,735 Balance sheet total 2024: € 578,735 ▼ 1% vs 2023 (€ 584,719) Unchanged	€ 563,573 Balance sheet total 2025: € 563,573 ▼ 3% vs 2024 (€ 578,735) Unchanged	▼ 3%
Employees (FTE)	1.6 Employees (FTE) 2022: 1.6 First fiscal year in the series	1.6 Employees (FTE) 2023: 1.6 Unchanged (1.6) Unchanged	2.2 Employees (FTE) 2024: 2.2 ▲ 0.6 vs 2023 (1.6) Unchanged	1.5 Employees (FTE) 2025: 1.5 ▼ 0.7 vs 2024 (2.2) Unchanged	▼ 0.7

Key figures of Apotheek D'HEER Pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Apotheek D'HEER Pharma?

What happened at Apotheek D'HEER Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 17, 2026 New annual accounts for financial year 2025: profit of € 1,157 (▼ 70% vs 2024). Source: NBB ↗
Jan 13, 1992 New establishment in Lokeren. KBO
Dec 19, 1991 Start of the company according to the CBE. KBO

In short

From € 38,726 profit in 2022 to € 1,157 profit in 2025.

Paid € 2,288 in corporate taxes since 2022.

Best year ever: 2022, with € 38,726 profit.

On average € 67,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Axarka Comm V

Apotheek D'HEER Pharma

Behind Apotheek D'HEER Pharma is Axarka Comm V.

Directors

According to the 2025 annual accounts

Axarka Comm V

Administrator-manager · represented by D'heer Katrien

Establishments

Establishment units

Physical locations of this company

Registered office

Doorslaardorp 85

9160 Lokeren

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0446.071.227

VAT number

BE 0446.071.227

Registered office

Doorslaardorp 85, 9160 Lokeren

Names & denominations

Apotheek D'HEER Pharma

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

19 December 1991

Peppol

Active · Active since 18 Aug 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek D'HEER Pharma

Warning lights

Financials

What happened to Apotheek D'HEER Pharma?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions